Douglas Lane & Associates LLC Has $3.52 Million Position in The Procter & Gamble Company (NYSE:PG)

Douglas Lane & Associates LLC decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 2.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,336 shares of the company’s stock after selling 576 shares during the quarter. Douglas Lane & Associates LLC’s holdings in Procter & Gamble were worth $3,522,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. CVA Family Office LLC boosted its holdings in shares of Procter & Gamble by 1.6% during the third quarter. CVA Family Office LLC now owns 9,724 shares of the company’s stock worth $1,684,000 after acquiring an additional 151 shares during the period. McGuire Investment Group LLC lifted its holdings in Procter & Gamble by 5.4% during the 3rd quarter. McGuire Investment Group LLC now owns 2,687 shares of the company’s stock worth $465,000 after purchasing an additional 137 shares during the last quarter. McCarthy & Cox bought a new stake in Procter & Gamble in the 3rd quarter valued at $221,000. Exchange Bank grew its holdings in Procter & Gamble by 0.7% in the 3rd quarter. Exchange Bank now owns 22,858 shares of the company’s stock valued at $3,959,000 after buying an additional 160 shares in the last quarter. Finally, Ayrshire Capital Management LLC increased its position in Procter & Gamble by 1.9% during the 3rd quarter. Ayrshire Capital Management LLC now owns 31,343 shares of the company’s stock worth $5,429,000 after buying an additional 590 shares during the period. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Price Performance

PG stock opened at $171.09 on Monday. The Procter & Gamble Company has a 1 year low of $141.66 and a 1 year high of $177.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The stock has a market cap of $403.80 billion, a price-to-earnings ratio of 27.96, a P/E/G ratio of 3.67 and a beta of 0.41. The company has a 50 day simple moving average of $171.48 and a 200 day simple moving average of $166.81.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.37 EPS. Research analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.35%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.69%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on PG. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. JPMorgan Chase & Co. increased their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. TD Cowen started coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Finally, Citigroup lifted their price objective on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $176.21.

Insider Activity

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at $6,325,360. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock valued at $65,140,718 over the last quarter. 0.17% of the stock is owned by company insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.